Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02556138 · ClinicalTrials.gov registry record · NA
Endoscopic Intragastric Balloon Placement for Weight Loss in Liver Transplant Waitlist Candidates
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02556138: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02556138 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02556138, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the Orbera Intragastric Balloon is a safe and effective means for weight loss and improved metabolic disease in patients with cirrhosis requiring liver transplantation.
Interventions
- DEVICE ORBERA Intragastric Balloon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2016-11-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02556138
The ClinicalTrials.gov registry entry for NCT02556138 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ORBERA Intragastric Balloon is the first listed.
NCT02556138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02556138 about?
NCT02556138 is a clinical study titled "Endoscopic Intragastric Balloon Placement for Weight Loss in Liver Transplant Waitlist Candidates". The purpose of this study is to determine whether the Orbera Intragastric Balloon is a safe and effective means for weight loss and improved metabolic disease in patients with cirrhosis requiring liver transplantation.
What is the current status of trial NCT02556138?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2015-09-01. Estimated completion is 2016-11-03.
What interventions are being tested in trial NCT02556138?
The interventions under investigation include: ORBERA Intragastric Balloon (DEVICE).
Who is sponsoring clinical trial NCT02556138?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.